Experts' recommendations for the management of cardiogenic shock in children

Olivier Brissaud1, Astrid Botte2, Gilles Cambonie3

  • 1Unité de Réanimation Pédiatrique et Néonatale, Hôpital des Enfants, CHU Pellegrin Enfants, Place Amélie Raba Léon, 33000, Bordeaux, France. Olivier.brissaud@chu-bordeaux.fr.

Annals of Intensive Care
|February 17, 2016
PubMed

Insights

This study provides expert recommendations for managing pediatric cardiogenic shock, a rare condition in children. It emphasizes early recognition, clinical/echocardiographic assessment, and multidisciplinary care for critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Pediatric Cardiology
  • Clinical Recommendations

Background:

  • Cardiogenic shock, characterized by acute circulatory failure from myocardial dysfunction, is exceptionally rare in children.
  • No international guidelines currently exist for managing pediatric cardiogenic shock.
  • Recent expert recommendations for adult cardiogenic shock management have been published.

Purpose of the Study:

  • To develop evidence-based recommendations for the management of cardiogenic shock in critically ill children.
  • To provide guidance on early recognition, hemodynamic monitoring, and therapeutic strategies.
  • To address the need for standardized care in pediatric cardiogenic shock.

Main Methods:

  • Development of recommendations by an expert group from the French Group for Pediatric Intensive Care and Emergencies (GFRUP).
  • Utilized the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system.
  • Recommendations cover early signs, patient pathway, management principles, monitoring, and circulatory support.

Main Results:

  • Key management principles focus on clinical and echocardiographic assessment.
  • Limited pharmacological options are documented for pediatric cardiogenic shock.
  • Recommendations highlight the importance of organized circulatory support and transfer criteria.

Conclusions:

  • Pediatric cardiogenic shock requires specialized, multidisciplinary care involving pediatric intensivists, cardiologists, and surgeons.
  • Effective communication among emergency services, pediatric departments, and intensive care units is crucial.
  • Regular follow-up by pediatric intensivist cardiologists and pediatricians is essential for vulnerable children.

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.8K
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
1.0K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
743
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
671
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
512